Hidenobu Andoh

Title: Hidenobu Andoh: Innovator in Sustained-Release Tablet Technology

Introduction

Hidenobu Andoh is a notable inventor based in Gifu, Japan. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of sustained-release multi-granule tablets. With a total of 3 patents to his name, Andoh's work focuses on enhancing drug bioavailability and minimizing absorption variability among patients.

Latest Patents

One of Hidenobu Andoh's latest patents is a sustained-release multi-granule tablet that is obtained by compressing sustained-release granules containing a basis and a formulation adjuvant. Each granule is coated with a layer of the formulation adjuvant and/or a mixture of the formulation adjuvant and the basis. This innovative tablet releases an active substance at a suitable velocity into the digestive tract, thereby minimizing the imbalance in drug absorption among individual patients and achieving maximum bioavailability. Another patent by Andoh also describes a similar sustained-release multi-granule tablet, which contains an active substance and a formulation adjuvant. This design aims to reduce variability in drug absorption, ensuring that patients receive optimal therapeutic effects.

Career Highlights

Hidenobu Andoh is currently associated with Eisai Company, Limited, where he continues to advance his research and development efforts in pharmaceutical innovations. His work has been instrumental in improving drug formulations that cater to diverse patient needs.

Collaborations

Andoh has collaborated with esteemed colleagues such as Sumio Watanabe and Yasuo Miyake. Their combined expertise has contributed to the successful development of innovative pharmaceutical solutions.

Conclusion

Hidenobu Andoh's contributions to sustained-release tablet technology exemplify the importance of innovation in the pharmaceutical industry. His patents reflect a commitment to enhancing patient care through improved drug delivery systems.